Ampelopsin Inhibits Breast Cancer Glucose Metabolism Reprogramming Based on Network Pharmacology and Molecular Docking
Author:
Publisher
Walter de Gruyter GmbH
Subject
Oncology
Link
https://www.techscience.com/oncologie/v24n3/49719/pdf
Reference43 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer Journal for Clinicians,2021
2. Fangchinoline inhibits migration and causes apoptosis of human breast cancer MDA-MB-231 cells;Wang;Oncology Letters,2017
3. Trastuzumab emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;The New England Journal of Medicine,2019
4. Endocrine-responsive breast cancer and strategies for combating resistance;Ali;Nature Reviews Cancer,2002
5. Mechanisms of disease: Understanding resistance to HER2-targeted therapy in human breast cancer;Nahta;Nature Clinical Practice Oncology,2006
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma;Current Medicinal Chemistry;2024-03-15
2. A commentary: Role of MTA1: a novel modulator reprogramming mitochondrial glucose metabolism;Oncologie;2023-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3